These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22140087)

  • 21. Species and mediator specific TLR4 antagonism in primary human and murine immune cells by βGlcN(1↔1)αGlc based lipid A mimetics.
    Chebrolu C; Artner D; Sigmund AM; Buer J; Zamyatina A; Kirschning CJ
    Mol Immunol; 2015 Oct; 67(2 Pt B):636-41. PubMed ID: 26319313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetraacylated lipid A and paclitaxel-selective activation of TLR4/MD-2 conferred through hydrophobic interactions.
    Resman N; Oblak A; Gioannini TL; Weiss JP; Jerala R
    J Immunol; 2014 Feb; 192(4):1887-95. PubMed ID: 24420921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lipopolysaccharide from Capnocytophaga canimorsus reveals an unexpected role of the core-oligosaccharide in MD-2 binding.
    Ittig S; Lindner B; Stenta M; Manfredi P; Zdorovenko E; Knirel YA; dal Peraro M; Cornelis GR; Zähringer U
    PLoS Pathog; 2012; 8(5):e1002667. PubMed ID: 22570611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationship of synthetic toll-like receptor 4 agonists.
    Stöver AG; Da Silva Correia J; Evans JT; Cluff CW; Elliott MW; Jeffery EW; Johnson DA; Lacy MJ; Baldridge JR; Probst P; Ulevitch RJ; Persing DH; Hershberg RM
    J Biol Chem; 2004 Feb; 279(6):4440-9. PubMed ID: 14570885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cellular Toll-like receptor 4 antagonist E5531 can act as an agonist in horse whole blood.
    Bryant CE; Ouellette A; Lohmann K; Vandenplas M; Moore JN; Maskell DJ; Farnfield BA
    Vet Immunol Immunopathol; 2007 Apr; 116(3-4):182-9. PubMed ID: 17320193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemistry and cell biology of bacterial endotoxins.
    Holst O; Ulmer AJ; Brade H; Flad HD; Rietschel ET
    FEMS Immunol Med Microbiol; 1996 Dec; 16(2):83-104. PubMed ID: 8988390
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins.
    Zughaier SM; Zimmer SM; Datta A; Carlson RW; Stephens DS
    Infect Immun; 2005 May; 73(5):2940-50. PubMed ID: 15845500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol.
    Kawasaki K; Akashi S; Shimazu R; Yoshida T; Miyake K; Nishijima M
    J Endotoxin Res; 2001; 7(3):232-6. PubMed ID: 11581576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interpretation of biological activity data of bacterial endotoxins by simple molecular models of mechanism of action.
    Frecer V; Ho B; Ding JL
    Eur J Biochem; 2000 Feb; 267(3):837-52. PubMed ID: 10651822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 Reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations.
    Muta T; Takeshige K
    Eur J Biochem; 2001 Aug; 268(16):4580-9. PubMed ID: 11502220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.
    Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
    mBio; 2017 May; 8(3):. PubMed ID: 28487429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14.
    Akashi S; Saitoh S; Wakabayashi Y; Kikuchi T; Takamura N; Nagai Y; Kusumoto Y; Fukase K; Kusumoto S; Adachi Y; Kosugi A; Miyake K
    J Exp Med; 2003 Oct; 198(7):1035-42. PubMed ID: 14517279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble CD14 discriminates slight structural differences between lipid as that lead to distinct host cell activation.
    Asai Y; Makimura Y; Kawabata A; Ogawa T
    J Immunol; 2007 Dec; 179(11):7674-83. PubMed ID: 18025213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taking toll: lipid A mimetics as adjuvants and immunomodulators.
    Persing DH; Coler RN; Lacy MJ; Johnson DA; Baldridge JR; Hershberg RM; Reed SG
    Trends Microbiol; 2002; 10(10 Suppl):S32-7. PubMed ID: 12377566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition.
    Akashi S; Nagai Y; Ogata H; Oikawa M; Fukase K; Kusumoto S; Kawasaki K; Nishijima M; Hayashi S; Kimoto M; Miyake K
    Int Immunol; 2001 Dec; 13(12):1595-9. PubMed ID: 11717200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulating potency: Physicochemical characteristics are a determining factor of TLR4-agonist nanosuspension activity.
    Dowling QM; Sivananthan SJ; Guderian JA; Moutaftsi M; Chesko JD; Fox CB; Vedvick TS; Kramer RM
    J Pharm Sci; 2014 Mar; 103(3):879-89. PubMed ID: 24464844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.
    Maeshima N; Evans-Atkinson T; Hajjar AM; Fernandez RC
    J Biol Chem; 2015 May; 290(21):13440-53. PubMed ID: 25837248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A.
    Yamakawa N; Ohto U; Akashi-Takamura S; Takahashi K; Saitoh S; Tanimura N; Suganami T; Ogawa Y; Shibata T; Shimizu T; Miyake K
    Int Immunol; 2013 Jan; 25(1):45-52. PubMed ID: 22962435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition.
    Delude RL; Savedra R; Zhao H; Thieringer R; Yamamoto S; Fenton MJ; Golenbock DT
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9288-92. PubMed ID: 7568119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of monomeric and dimeric secreted MD-2. Endotoxin.sCD14 and Toll-like receptor 4 ectodomain selectively react with the monomeric form of secreted MD-2.
    Teghanemt A; Widstrom RL; Gioannini TL; Weiss JP
    J Biol Chem; 2008 Aug; 283(32):21881-9. PubMed ID: 18519568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.